Accelerating our US expansion : four major US projects secured powering our growth

Since the opening of our Efor office in Boston in 2023, we have built a solid foundation across the U.S. — and in just two years, our teams have succeeded in establishing Efor as a trusted partner within the American biopharma ecosystem.

Today, we are proud to be supporting four major strategic industrial projects across the United States, each representing a key investment in the future of biomanufacturing.

In North Carolina, our teams are contributing to two pioneering initiatives:

• A next-generation biologics manufacturing program, supporting the Commissioning & Qualification of a brand-new facility in the Research Triangle area. We are delivering CQ across full scopes: utilities, HVAC, facilities, warehouse, process systems, and digital validation workflows.
• An East Coast production site for advanced therapies, dedicated to metabolic and specialty medicines. Our experts lead CQ activities covering documentation, warehouse, HVAC, assembly & packaging, and integrated delivery.

In Indiana, we are contributing to a landmark peptide therapeutics facility, part of a multi-year program to qualify critical systems and ensure operational readiness for a cutting-edge peptide manufacturing campus. From process utilities to digital validation, our experts are helping accelerate time-to-market for future therapies.

In Massachusetts, we play a key role in the expansion of mRNA manufacturing capacity in the Boston area. Our mission includes critical utilities qualification, equipment validation, and best-in-class digital execution using Kneat. 

These projects demonstrate the trust placed in Efor’s compliance excellence, our ability to operate in complex GMP environments, and our growing footprint close to the largest life sciences investment hubs in the United States.

A turning point for Efor

Beyond the technical scope, these wins highlight something essential:

U.S. teams are choosing Efor for 

– Our technical depth,
– Our project delivery culture,
– And our ability to bring scalable, expert-driven solutions.

They confirm that Efor’s international reach, combined with strong local capabilities, makes a true difference.
We are no longer simply entering the U.S. market — we are becoming a recognized player in its most strategic biopharma projects.

A huge thank you

We extend our warmest thanks to our teams in the U.S. and worldwide.

Your expertise, commitment, and collaboration are the reason we’re trusted with projects that shape the future of healthcare.

And this is just the beginning

The U.S. market remains one of the most transformative opportunities for Efor — and we’re ready to keep building, delivering, and raising the standard of Life Science engineering together.